Interruption of BTK Inhibitor Improves Response to SARS-CoV-2 Booster Vaccination in Patients with Chronic Lymphocytic Leukemia
Consent Codes
GRUFocus / Diseases
Immunogenicity, VaccineStudy Design
Prospective Longitudinal CohortData Types
UnspecifiedSubjects
81